Tech-Bank(SZ:002124)2022-12-06 02:48Group 1: Vaccine Products - The main products in the vaccine sector include: pig fever heat-resistant protective vaccine, pig reproductive and respiratory syndrome virus live vaccine, pig infectious gastroenteritis and pig epidemic diarrhea inactivated vaccine, pig circovirus type 2 inactivated vaccine, and pseudorabies live vaccine. The sales of the pig circovirus vaccine have remained stable, while the sales of the pig fever heat-resistant protective vaccine and the pig infectious gastroenteritis and pig epidemic diarrhea inactivated vaccine have seen significant year-on-year increases [1][2]. Group 2: Competitive Advantages - The high pathogenic pig reproductive and respiratory syndrome heat-resistant protective live vaccine (JXA1-R strain) utilizes advanced cell suspension culture technology for virus antigen production. This method offers high automation, consistent antigen titers, minimal batch variation, and reduced contamination risks. The product can be stored long-term at 2-8°C, ensuring stability and efficacy. It is the only high pathogenic pig blue ear disease vaccine produced using this technology in China, marking a significant upgrade in product quality within the industry [2]. Group 3: Meat Products Distribution - The sales channels for fresh and processed meat products include specialty stores, supermarkets, catering enterprises, and e-commerce. In the future, central kitchens are expected to become a major consumption method in large cities, with catering and community fresh food stores serving as primary supply channels. The company plans to explore the market for finely segmented products and develop convenient foods to enhance its food service capabilities. Since 2016, the company has invested in research and distribution of meat processing, aiming to offer differentiated and competitive deep-processed meat products based on these sales channels [3].